Medicinershoppen ApS: Financial statements 2023
CVR: 40600434
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Medicinershoppen ApS (CVR 40600434) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 496,324 and a net result of DKK 91,691 compared with DKK 39,525 the year before. That is a decrease of 2.6% compared with the year before. The profit margin was 18.5%. Equity in the 2023 report amounted to DKK 244,080. The solvency ratio was 76.6%.
- Revenue
- DKK 496,324
- Gross Profit
- DKK 138,448
- Profit/Loss
- DKK 91,691
- Equity
- DKK 244,080
- Total Assets
- DKK 318,699
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 496 t. | 138 t. | 92 t. | 244 t. | - |
| 2022 | 509 t. | 51 t. | 40 t. | 251 t. | - |
| 2021 | 569 t. | 220 t. | 171 t. | 211 t. | - |
| 2020 | 257 t. | 84 t. | 62 t. | 102 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Medicinershoppen ApS has published its annual report for 2022. Revenue came to DKK 509,420, and the net result was DKK 39,525.
About Medicinershoppen ApS
Medicinershoppen ApS is a Danish company of the type Anpartsselskab based in Ribe, founded in 2019. The company is registered under the industry Detailhandel med andre medicinske og ortopædiske artikler. The management consists of Martin Hollænder, Jacob Holmen Terkelsen and Kasper Bang Bredal. The company is owned by Martin Hollænder, Jacob Holmen Terkelsen and K. Bredal Invest ApS. In 2025, the company reported revenue of DKK 518,176 and a net result of DKK 118,512 compared with DKK 158,971 the year before. Equity in the 2025 report amounted to DKK 363,442.